An article this week explores the feasibility of implementing a hybrid PET/MR system. How likely are you to invest?
An article at Diagnostic Imaging this week explores the feasibility of implementing a hybrid PET/MR system. Radiologists are excited about this technology, but so far, interest in the U.S. has been mainly from large research institutions.
So are you considering investing in this technology?
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.